Santaris Pharma Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $450M

Santaris Pharma General Information

Description

Developer of ribonucleic acid (RNA) targeted therapies. The company's Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine is designed to deliver single-stranded Locked Nucleic Acid (LNA) based drug candidates across an array of disease states, including cancer, cardiovascular disease, infectious and inflammatory diseases and rare genetic disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Fremtidsvej 3
  • 2970 Horsholm
  • Denmark
+45 45
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Fremtidsvej 3
  • 2970 Horsholm
  • Denmark
+45 45

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Santaris Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 31-Aug-2014 $450M Completed Generating Revenue
5. Later Stage VC 20-Jun-2012 Completed Generating Revenue
4. Grant 15-May-2008 Completed Generating Revenue
3. Later Stage VC (Series C) 18-Dec-2007 Completed Generating Revenue
2. Early Stage VC (Series B) 15-Mar-2006 $53.7M $59.1M Completed Generating Revenue
1. Early Stage VC 29-Jun-2005 $5.35M $5.35M Completed Product Development
To view Santaris Pharma’s complete valuation and funding history, request access »

Santaris Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Santaris Pharma Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
BankInvest Biotech Ventures Venture Capital Minority
DKA Capital PE/Buyout Minority
Dansk Erhvervsinvestering Venture Capital Minority
Forbion Venture Capital Minority
Gilde Healthcare PE/Buyout Minority
You’re viewing 5 of 16 investors. Get the full list »

Santaris Pharma Investments (1)

Santaris Pharma’s most recent deal was a Corporate Asset Purchase with RNA teknologi. The deal was made on 01-Jan-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
RNA teknologi 01-Jan-2007 Corporate Asset Purchase Buildings and Property
To view Santaris Pharma’s complete investments history, request access »

Santaris Pharma FAQs

  • When was Santaris Pharma founded?

    Santaris Pharma was founded in 2003.

  • Where is Santaris Pharma headquartered?

    Santaris Pharma is headquartered in Horsholm, Denmark.

  • What is the size of Santaris Pharma?

    Santaris Pharma has 1 total employees.

  • What industry is Santaris Pharma in?

    Santaris Pharma’s primary industry is Drug Discovery.

  • Is Santaris Pharma a private or public company?

    Santaris Pharma is a Private company.

  • What is the current valuation of Santaris Pharma?

    The current valuation of Santaris Pharma is .

  • What is Santaris Pharma’s current revenue?

    The current revenue for Santaris Pharma is .

  • How much funding has Santaris Pharma raised over time?

    Santaris Pharma has raised $100M.

  • Who are Santaris Pharma’s investors?

    BankInvest Biotech Ventures, DKA Capital, Dansk Erhvervsinvestering, Forbion, and Gilde Healthcare are 5 of 16 investors who have invested in Santaris Pharma.

  • When was Santaris Pharma acquired?

    Santaris Pharma was acquired on 31-Aug-2014.

  • Who acquired Santaris Pharma?

    Santaris Pharma was acquired by Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process